6th Annual Gene Therapy for CNS Summit
![48817-–-6th-Gene-Therapy-for-CNS-Summit-2](https://prcclinical.com/wp-content/uploads/48817-–-6th-Gene-Therapy-for-CNS-Summit-2-1269x349.png)
November 20-22, 2024
Boston, MA
The 6th Gene Therapy for CNS Summit will return to Boston from November 20–22, 2024, with an agenda centered on enhancing biodistribution and advancing CNS gene therapies into the clinic. Against the backdrop of a notable rise in IND submissions for neurological diseases and promising results from novel capsids, the conference features a pertinent program highlighting the analysis of novel vectors for optimized gene delivery to the central nervous system, strategies for translational studies and advancing therapies into clinical trials, and discussions on ideal administration routes and making gene therapies for common CNS diseases a reality.
As a trusted partner for small to mid-size biotech companies for over twenty years, PRC Clinical has extensive experience managing complex CNS gene therapy studies. We provide specialized trial management and strategic consultancy services for companies entering the clinic, supporting programs from Phase I First-in-Human studies through late-phase clinical trials.